No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Healthcare Information Services
FINDEX Inc., a company established in Tokyo in 1985, focuses on the creation, production, and distribution of medical technology systems across Japan. Their portfolio features Claio, a comprehensive medical imaging database management system utilized by hospitals of all sizes, and C-Note, a dedicated platform for managing patient progress notes. They also offer DocuMaker, a sophisticated document and data management solution engineered with various input tools to boost efficiency, and the GAP/GAP-screener, which is an advanced gaze analyzing perimeter. Additionally, FINDEX Inc. develops mobile applications for smartphones. Their services cater to a wide range of medical clients, including hospitals, clinics, and other healthcare institutions. The organization adopted its current name, FINDEX Inc., in November 2014, having previously operated as PSC Inc.
www.findex.co.jpNo one on the platform currently holds 3649.T.
No tracked institution reports a position in 3649.T as of their last filing.
No one on the platform has traded 3649.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 33.9% | 40.2% | 38.8% | — | — | — |
| Rev. Growth % | 4.6% | 8.8% | ||||
| Profit Margin % | 20.6% | 17.9% | 14.9% | |||
| Free Cash Flow Margin % | 26.4% | 19.3% | 21.3% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $6.2B | +0.8% | $53.20 | $53.20–$53.20 | — | 1 |
| 2027 | $7.1B | +14.0% | $61.40 | $61.40–$61.40 | — | 1 |
| 2028 | $7.7B | +8.9% | $75.70 | $75.70–$75.70 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| -0.09% |
| $14.2B |
| — |
| 3902.TMedical Data Vision Co., Ltd. | $1684.00 | +0.00% | $63.8B | — |
| 3939.TKanamic Network Co.,LTD | $490.00 | -0.61% | $23.3B | — |
Source: Financial Modeling Prep · peers by sector/industry